Evidence for PDGFRA, PDGFRB and KIT deregulation in an NSCLC patient [3]

British Journal of Cancer

Volumn 96, Issue 1, 2007, Pages 180-181

  Negri, T ^a   Casieri, P ^a   Miselli, F ^a   Orsenigo, M ^a   Piacenza, C ^a   Stacchiotti, S ^a   Bidoli, P ^a   Casali, P G ^a   Pierotti, M A ^a   Tamborini, E ^a   Pilotti, S ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; IMATINIB; NAVELBINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; STEM CELL FACTOR;

ADJUVANT THERAPY; CLINICAL TRIAL; DRUG EFFICACY; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; CHORDOMA; DISEASE PROGRESSION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PIPERAZINES; PROTO-ONCOGENE PROTEINS C-KIT; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; SENSITIVITY AND SPECIFICITY;

EID: 33846188561     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603542     Document Type: Letter

References (5)

1. Bunn Jr PA, Dziadziuszko R, Varella-Garcia M, Franklin WA, Witta SE, Kelly K, Hirsch FR (2006) Biological markers for non-small cell lung cancer patient selection for epidermal growth factor receptor tyrosine kinase inhibitor therapy. Clin Cancer Res 12: 3652-3656
2. Casali PG, Messina A, Stacchiotti S, Tamborini E, Crippa F, Gronchi A, Orlandi R, Ripamonti C, Spreafico C, Bertieri R, Bertulli R, Colecchia M, Fumagalli E, Greco A, Grosso F, Olmi P, Pierotti MA, Pilotti S (2004) Imatinib mesylate in chordoma. Cancer 101: 2086-2097
3. Pietras K (2004) Increasing tumor uptake of anticancer drugs with imatinib. Semin Oncol 31: 18-23
4. Tamborini E, Miselli F, Negri T, Lagonigro MS, Staurengo S, Dagrada GD, Stacchiotti S, Pastore E, Gronchi A, Perrone F, Carbone A, Pierotti MA, Casali PG, Pilotti S (2006) Molecular and biochemical analysis of PDGFRB, PDGFRA and KIT receptors in chordomas. Clin Cancer Res 12(23): 6920-6928
5. Vlahovic G, Rabbani ZN, Herndon II JE, Dewhirst MW, Vujaskovic Z (2006) Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. Br J Cancer 95: 1013-1019